PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11459457-1	2001	With the aim of generating gene delivery systems for tumor targeting, we have synthesized a conjugate consisting of polyethylenimine (PEI) covalently modified with epidermal growth factor (EGF) peptides.	Polyethyleneimine	134-137	epidermal growth factor	Mus musculus	164-187	
12932649-2	2003	Polyethylenimine (PEI)/DNA complexes ("polyplexes") conjugated with the cell-binding ligand transferrin (Tf) or epidermal growth factor (EGF) were used to achieve receptor-mediated endocytosis.	Polyethyleneimine	0-16	epidermal growth factor	Mus musculus	112-135	
12932649-2	2003	Polyethylenimine (PEI)/DNA complexes ("polyplexes") conjugated with the cell-binding ligand transferrin (Tf) or epidermal growth factor (EGF) were used to achieve receptor-mediated endocytosis.	Polyethyleneimine	0-16	epidermal growth factor	Mus musculus	137-140	
12932649-2	2003	Polyethylenimine (PEI)/DNA complexes ("polyplexes") conjugated with the cell-binding ligand transferrin (Tf) or epidermal growth factor (EGF) were used to achieve receptor-mediated endocytosis.	Polyethyleneimine	18-21	epidermal growth factor	Mus musculus	112-135	
12932649-2	2003	Polyethylenimine (PEI)/DNA complexes ("polyplexes") conjugated with the cell-binding ligand transferrin (Tf) or epidermal growth factor (EGF) were used to achieve receptor-mediated endocytosis.	Polyethyleneimine	18-21	epidermal growth factor	Mus musculus	137-140